RHOKYRO
Dead / Abandoned — Abandoned — failure to respond (as of 18 Mar 2021)
What this means for you
This application is over — abandoned 26 Feb 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88401758
- Mark type
- Stylized text
- Filed
- 25 Apr 2019
- Abandoned
- 26 Feb 2021
- Attorney of record
- Michael J. Leonard
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals and pharmaceutical preparations, namely, Anti-infectives, anti-inflammatories, antibacterial pharmaceuticals, antibiotics, antifungal preparations, antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; pharmaceutical preparations and pharmaceutical agents for the treatment of Wilson's disease
Owner
- Kadmon Pharmaceuticals, LLC, Warrendale, PA, US
Prosecution history
- 18 Mar 2021 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 18 Mar 2021 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 25 Aug 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 25 Aug 2020 — NON-FINAL ACTION E-MAILED
- 25 Aug 2020 — NON-FINAL ACTION WRITTEN
- 25 Aug 2020 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 21 Aug 2020 — ASSIGNED TO LIE
- 24 Jan 2020 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 24 Jan 2020 — LETTER OF SUSPENSION E-MAILED
- 24 Jan 2020 — SUSPENSION LETTER WRITTEN
- 16 Jan 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 15 Jan 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 15 Jan 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 16 Jul 2019 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 16 Jul 2019 — NON-FINAL ACTION E-MAILED